Impact Assessment of COVID-19 Outbreak on Targeted..

Creó nuevo artículo

4 w

Impact Assessment of COVID-19 Outbreak on Targeted Therapeutics Market | #targeted Therapeutics Market

Impact Assessment of COVID-19 Outbreak on Targeted Therapeutics Market

Impact Assessment of COVID-19 Outbreak on Targeted Therapeutics Market

In October 2020, Bristol-Myers Squibb and MyoKardia, Inc. announced a definitive merger agreement, under which Bristol-Myers Squibb will acquire MyoKardia for US$ 13.1 Bn, or US$ 225.00 per share in cash.

Me gusta

Comentario

Compartir